Skip to main content
. Author manuscript; available in PMC: 2023 Dec 3.
Published in final edited form as: Blood Rev. 2022 Aug 2;57:100996. doi: 10.1016/j.blre.2022.100996

Table 3.

Clinical trials in MLL-rearranged AML.

Mutation Study regimen Trial identifier
MLL-rearranged AML
MLL-rearranged or NPM1mut DSP-5336 (menin-MLL inhibitor) NCT04988555
MLL-rearranged or NPM1mut SNDX-5613 (menin-MLL inhibitor) NCT04065399
None specified; relapsed or refractory AML KO-539 (menin-MLL inhibitor) NCT04067336
MLL-rearranged AML EPZ-5676 (DOT1L inhibitor) NCT01684150